The collaboration provides VedaBio access to essential CRISPR IP, accelerating the development of customised diagnostic ...

Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...

Coronavirus Disease 2019 (COVID-19) has driven the use of nucleic acid testing technology in clinical testing. There is a growing need for point-of-care testing (POCT) devices that can integrate ...

Scientists hope genetically modified mice will curb the spread of Lyme disease. They headed to Nantucket — home to a large ...

A study using CRISPR restored brain connectivity and made the brain more resilient to seizures, which are often seen in a ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...